home All News open_in_new Full Article
“LEQEMBI®” (lecanemab) IV Maintenance Dosing for the Treatment of Early Alzheimer’s Disease Approved in China
today 7 d. ago attach_file Economics
attach_file
Events
attach_file
Other
attach_file
Economics
attach_file
Other
attach_file
Economics
attach_file
Other
attach_file
Politics
attach_file
Politics
attach_file
Other
attach_file
Economics
attach_file
Economics
attach_file
Other
attach_file
Other
attach_file
Economics
ID: 868830535